Drug Trial Radar · NCT04677972
SPI-1005 for the Treatment of Meniere's Disease
Last checked: Nov 19, 2026Latest source record: Jul 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
220
Actual
Start
Aug 2, 2022
Primary completion
Sep 19, 2023
Study completion Jul 25, 2024
Sponsor
- Lead sponsor
- Sound Pharmaceuticals, IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Dec 21, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a randomized, double-blind, placebo-controlled, multi-center clinical trial (RCT) with open-label extension study (OLE), of SPI-1005 in adult subjects with definite Meniere's disease with active symptoms within three months preceding study enrollment.
Conditions
- Meniere Disease
- Ménière
Interventions
EbselenDrug
Glutathione peroxidase mimetic
PlaceboDrug
Matching placebo containing excipients
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse EventsTime frame: 84 days
- Change in Low Frequency Hearing Thresholds Measured by Pure Tone AudiometryTime frame: 84 days
- Change in Words-in-Noise Test ScoreTime frame: 84 days
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
University of Arkansas for Medical Sciences
Little Rock, Arkansas
University of Southern California
Los Angeles, California
House Clinic
Los Angeles, California
Sacramento Ear, Nose, & Throat
Roseville, California
George Washington University
Washington D.C., District of Columbia
ENT and Allergy Associates of Florida
Boca Raton, Florida
Indiana University
Indianapolis, Indiana
Kansas University Medical Center
Kansas City, Kansas
Advanced ENT & Allergy
Louisville, Kentucky
Piedmont Ear, Nose & Throat Associates
Winston-Salem, North Carolina
Thomas Jefferson University
Philadelphia, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.